| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.3 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |